Calcimedica, Common Stock Stock Fundamentals
| CALC Stock | 2.78 0.03 1.07% |
CalciMedica, Common Stock fundamentals help investors to digest information that contributes to CalciMedica, Common's financial success or failures. It also enables traders to predict the movement of CalciMedica, Stock. The fundamental analysis module provides a way to measure CalciMedica, Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CalciMedica, Common stock.
At present, CalciMedica, Common's Research Development is projected to decrease significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 24.9 M, whereas Depreciation And Amortization is forecasted to decline to about 55.1 K. CalciMedica, | Select Account or Indicator |
CalciMedica, Common Stock Company Shares Outstanding Analysis
CalciMedica, Common's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current CalciMedica, Common Shares Outstanding | 13.48 M |
Most of CalciMedica, Common's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CalciMedica, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CalciMedica, Shares Outstanding Historical Pattern
Today, most investors in CalciMedica, Common Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CalciMedica, Common's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CalciMedica, Common shares outstanding as a starting point in their analysis.
CalciMedica, Common Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
CalciMedica, Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, CalciMedica, Common Stock has 13.48 M of shares currently outstending. This is 92.53% lower than that of the Biotechnology sector and 87.38% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.64% higher than that of the company.
CalciMedica, Common Stock Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CalciMedica, Common's current stock value. Our valuation model uses many indicators to compare CalciMedica, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CalciMedica, Common competition to find correlations between indicators driving CalciMedica, Common's intrinsic value. More Info.CalciMedica, Common Stock is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, CalciMedica, Common's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CalciMedica, Common's earnings, one of the primary drivers of an investment's value.CalciMedica, Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CalciMedica, Common's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CalciMedica, Common could also be used in its relative valuation, which is a method of valuing CalciMedica, Common by comparing valuation metrics of similar companies.CalciMedica, Common is currently under evaluation in shares outstanding category among its peers.
CalciMedica, Common Current Valuation Drivers
We derive many important indicators used in calculating different scores of CalciMedica, Common from analyzing CalciMedica, Common's financial statements. These drivers represent accounts that assess CalciMedica, Common's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of CalciMedica, Common's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.0M | 2.8M | 8.8M | 9.0M | 8.1M | 5.1M | |
| Enterprise Value | 121.5M | (30.7M) | (4.5M) | (8.1M) | (9.4M) | (8.9M) |
CalciMedica, Common ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CalciMedica, Common's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CalciMedica, Common's managers, analysts, and investors.Environmental | Governance | Social |
CalciMedica, Fundamentals
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 17.09 M | ||||
| Shares Outstanding | 13.48 M | ||||
| Shares Owned By Insiders | 17.48 % | ||||
| Shares Owned By Institutions | 43.86 % | ||||
| Number Of Shares Shorted | 45.16 K | ||||
| Price To Book | 4.08 X | ||||
| EBITDA | (34.19 M) | ||||
| Net Income | (34.36 M) | ||||
| Total Debt | 4.03 M | ||||
| Book Value Per Share | 1.42 X | ||||
| Cash Flow From Operations | (25.73 M) | ||||
| Short Ratio | 1.68 X | ||||
| Earnings Per Share | (1.11) X | ||||
| Target Price | 17.0 | ||||
| Number Of Employees | 13 | ||||
| Market Capitalization | 37.88 M | ||||
| Total Asset | 12.19 M | ||||
| Retained Earnings | (146.06 M) | ||||
| Working Capital | 7.58 M | ||||
| Net Asset | 12.19 M |
About CalciMedica, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CalciMedica, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CalciMedica, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CalciMedica, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.2 M | 1.2 M | |
| Cost Of Revenue | 58 K | 55.1 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:Check out CalciMedica, Common Piotroski F Score and CalciMedica, Common Altman Z Score analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.11) | Return On Assets (0.65) | Return On Equity (0.84) |
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.